Evidence map›Paper›PMID 36611795›Full record

ArticleCells2022

Lower Metabolic Potential and Impaired Metabolic Flexibility in Human Lymph Node Stromal Cells from Patients with Rheumatoid Arthritis.

Tineke A de Jong, Johanna F Semmelink, Simone W Denis, Janne W Bolt, Mario Maas, Marleen G H van de Sande, Riekelt H L Houtkooper, Lisa G M van Baarsen

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Tineke A de JongLaboratory for Experimental Immunology and Department of Rheumatology & Clinical Immunology, Amsterdam UMC Location University of Amsterdam, 1105AZ Amsterdam, The Netherlands.
Johanna F SemmelinkLaboratory for Experimental Immunology and Department of Rheumatology & Clinical Immunology, Amsterdam UMC Location University of Amsterdam, 1105AZ Amsterdam, The Netherlands.
Simone W DenisLaboratory Genetic Metabolic Diseases, Amsterdam UMC Location University of Amsterdam, 1105AZ Amsterdam, The Netherlands.
Janne W BoltLaboratory for Experimental Immunology and Department of Rheumatology & Clinical Immunology, Amsterdam UMC Location University of Amsterdam, 1105AZ Amsterdam, The Netherlands.ORCID 0000-0001-5065-7439
Mario MaasDepartment of Radiology, Amsterdam UMC Location University of Amsterdam, 1105AZ Amsterdam, The Netherlands.
Marleen G H van de SandeLaboratory for Experimental Immunology and Department of Rheumatology & Clinical Immunology, Amsterdam UMC Location University of Amsterdam, 1105AZ Amsterdam, The Netherlands.
Riekelt H L HoutkooperLaboratory Genetic Metabolic Diseases, Amsterdam UMC Location University of Amsterdam, 1105AZ Amsterdam, The Netherlands.ORCID 0000-0001-9961-0842
Lisa G M van BaarsenLaboratory for Experimental Immunology and Department of Rheumatology & Clinical Immunology, Amsterdam UMC Location University of Amsterdam, 1105AZ Amsterdam, The Netherlands.ORCID 0000-0003-3346-8921
Amsterdam UMC Location University of Amsterdam · NLAmsterdam University Medical Centers · NLEmma Kinderziekenhuis · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cellular metabolism is important for determining cell function and shaping immune responses. Studies have shown a crucial role for stromal cells in steering proper immune responses in the lymph node microenvironment. These lymph node stromal cells (LNSCs) tightly regulate immune tolerance. We hypothesize that malfunctioning LNSCs create a microenvironment in which normal immune responses are not properly controlled, possibly leading to the development of autoimmune diseases such as rheumatoid arthritis (RA). Therefore, we set out to determine their metabolic profile during health and systemic autoimmunity. We included autoantibody positive individuals at risk of developing RA (RA-risk individuals), RA patients and healthy volunteers. All study subjects underwent lymph node biopsy sampling. Mitochondrial function in cultured LNSCs was assessed by quantitative PCR, flow cytometry, Seahorse and oleate oxidation assays. Overall, mitochondrial respiration was lower in RA(-risk) LNSCs compared with healthy LNSCs, while metabolic potential was only lower in RA LNSCs. To maintain basal mitochondrial respiration, all LNSCs were mostly dependent on fatty acid oxidation. However, RA(-risk) LNSCs were also dependent on glutamine oxidation. Finally, we showed that RA LNSCs have impaired metabolic flexibility. Our results show that the metabolic landscape of LNSCs is not only altered during established disease, but partly already in individuals at risk of developing RA. Future studies are needed to investigate the impact of restoring metabolic capacity in LNSC-mediated immunomodulation and disease progression.

Indexed as

Arthritis, RheumatoidHumansImmune ToleranceImmunityLymph NodesStromal Cellsautoimmunitylymph node stromal cells (LNSCs)mitochondrial respirationRA-risk individuals

Identifiers

PMID36611795
PMCPMC9818527
OpenAlexW4313436004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.